Health
Pfizer to cut stake in toothpaste maker Sensodyne Haleon to 24%
Consumer products company Haleon said on Monday that US drugmaker Pfizer, its major shareholder, will sell its stake in the company to about 24%.
Biden pushes for more women’s health research
President Joe Biden on Monday will issue an executive order expanding U.S. government research on women’s health and spend $200 million next year to better
U.S. agency calls for temporary payments to healthcare providers
The U.S. government said Friday it has called on states to make interim payments to healthcare providers affected by the cyberattack on UnitedHealth unit Health
The U.S. has supported the expanded use of CAR-T therapy
US health regulator advisers voted to authorise the use of Johnson & Johnson and Bristol Myers Squibb cell therapies like previous treatments on Friday, paving
Gilead CAR-T cancer treatment capacity to quadruple by 2026
Gilead Sciences will be able to quadruple its production of cancer cell therapies by 2026 thanks to improvements in US biotech manufacturing processes, the executive
Merck succeeds in late-stage trial for cervical cancer treatment
Merck said its Keytruda immunotherapy, in combination with chemoradiotherapy, met the primary endpoint of improving overall survival for newly diagnosed patients with a form of
AstraZeneca to buy Amolit Pharma for $1.05bn to boost rare disease portfolio
Drug maker AstraZeneca said on Thursday it will acquire rare endocrine disease company Amolyt Pharma for $1.05 billion in cash in a bid to boost
US FDA approves expanded use of Miruma drug for liver disease
The U.S. Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals’ oral drug for the treatment of pruritus caused by liver disease
Merck is testing a single dose of Gardasil 9 HPV vaccine
Merck & Co said on Wednesday it plans to conduct a clinical trial of its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy
Merck is testing a single dose of Gardasil 9 HPV vaccine
Merck & Co said on Wednesday it plans to conduct a clinical trial of its human papillomavirus vaccine Gardasil 9 to evaluate the efficacy and